» Articles » PMID: 17475465

Is Metabolic Syndrome X a Disorder of the Brain with the Initiation of Low-grade Systemic Inflammatory Events During the Perinatal Period?

Overview
Journal J Nutr Biochem
Date 2007 May 4
PMID 17475465
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

An imbalance between pro- and anti-inflammatory molecules occurs in metabolic syndrome X. High-energy diet, saturated fats and trans-fats during perinatal period could suppress Delta(6) and Delta(5) desaturases both in the maternal and fetal tissues, resulting in a decrease in the concentrations of long-chain polyunsaturated fatty acids (LCPUFAs): arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that have a negative feedback control on inflammation. EPA, DHA and AA augment endothelial nitric oxide synthesis, potentiate insulin action both in the peripheral tissues and brain and alter leptin production. LCPUFAs are essential for brain growth and development and synaptogenesis and modulate the action of several neurotransmitters and hypothalamic peptides. This suggests that metabolic syndrome X could be a disorder of the brain due to suboptimal LCPUFAs during perinatal period that triggers low-grade systemic inflammation, implying that perinatal strategies are needed to prevent its development.

Citing Articles

Syntaxin interacts with arachidonic acid to prevent diabetes mellitus.

Das U Lipids Health Dis. 2022; 21(1):73.

PMID: 35982452 PMC: 9389802. DOI: 10.1186/s12944-022-01681-3.


Potential Toxic Effects of Exposure to Titanium Silicon Oxide Nanoparticles in Male Rats.

Ghareeb S, Ragheb D, El-Sheakh A, Ashour M Int J Environ Res Public Health. 2022; 19(4).

PMID: 35206216 PMC: 8872251. DOI: 10.3390/ijerph19042029.


Prdm16-Mediated Browning is Involved in Resistance to Diet-Induced and Monosodium Glutamate-Induced Obesity.

Liang J, Jia Y, Yan H, Shen Q, Bian W, Zhao D Diabetes Metab Syndr Obes. 2021; 14:4351-4360.

PMID: 34737591 PMC: 8558318. DOI: 10.2147/DMSO.S335526.


Macronutrient intake during pregnancy in women with a history of obesity or gestational diabetes and offspring adiposity at 5 years of age.

Meinila J, Klemetti M, Huvinen E, Engberg E, Andersson S, Stach-Lempinen B Int J Obes (Lond). 2021; 45(5):1030-1043.

PMID: 33558642 PMC: 8081655. DOI: 10.1038/s41366-021-00762-0.


Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.

Kamal M, Shakil S, Nawaz M, Yu Q, Tweedie D, Tan Y CNS Neurol Disord Drug Targets. 2017; 16(7):820-827.

PMID: 28176640 PMC: 5831670. DOI: 10.2174/1871527316666170207160606.